Dans ce long-métrage entre Paris et Luberon, une jeune chanteuse accuse une star de l'opéra de l'avoir agressée lors des répétitions des "Noces de Figaro". Les tensions montent entre les générations, ...

Complement component 3, often called C3, is an essential protein of the immune system. This protein plays a vital role in the body’s innate immune system, providing the first line of defense against ...

Costco Direct automatically saves you money when you buy 2+ qualifying big-ticket items (appliances, TVs, furniture). Look for the red “Costco Direct” label. Combine items in the same promo (washer + ...

Paris-based trade show Maison&Objet returns in 2026, hosting a January and September edition. The first event of the year spotlights products across seven categories: Signature and Projects, Decor and ...

France 2 a demandé aux équipes de « Complément d’enquête » de retirer une séquence de leur reportage sur CNews quelques heures avant la diffusion, suite à la position contradictoire de l’Arcom qui ...

WASHINGTON — The U.S. Army announced updates to its Direct Commissioning Program, DCP, aimed at attracting top-tier professionals with specialized skills directly into its officer corps. The program ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...

Among people with sickle cell disease—an inherited blood disorder—acute chest syndrome (ACS) is the leading cause of death. The condition is the result of red blood cells becoming stiff, sticky, and ...

The luxury home design and fragrance brand L'Objet boasts an elegant boutique on New York City's Madison Avenue. The space, bathed in earthy hues, harmoniously blends handcrafted housewares, ...

Le nouvel épisode de « Complément d’Enquête », diffusé ce jeudi soir sur France 2, se concentre sur Jean-Luc Mélenchon. Le documentaire revient sur les méthodes parfois brutales du patron de La France ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...